Physician profile
Casey Laws
NPI 1568406650
$10,988.03
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $68.36 · 2021: $8,115 · 2022: $1,903 · 2023: $390 · 2024: $15.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,271.12 | 2019-2022 | |
| Abbvie INC. | $764.47 | 2019-2023 | |
| Medtronic, INC. | $170.44 | 2023 | Interstim |
| Mayne Pharma Commercial LLC | $101.68 | 2021-2024 | |
| Axonics, INC. | $89.50 | 2021-2023 | Axonics, Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $83.58 | 2019-2023 | |
| Pfizer INC. | $72.96 | 2021-2022 | |
| Meditrina | $56.68 | 2022-2023 | |
| Exeltis, USA INC. | $52.61 | 2021-2023 | Slynd |
| Hologic Sales and Service, LLC | $51.05 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $47.79 | 2019-2021 | |
| Therapeuticsmd, INC. | $46.85 | 2022 | |
| Avion Pharmaceuticals | $33.69 | 2022 | |
| Organon LLC | $25.66 | 2022 | |
| Myovant Sciences INC. | $17.40 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $17.37 | 2022 | |
| Roche Diagnostics Corporation | $15.13 | 2019 | |
| Evofem Biosciences, INC. | $14.05 | 2022 | |
| Novo Nordisk INC | $13.92 | 2023 | |
| Glaxosmithkline, LLC. | $13.54 | 2023 | Zejula, Jemperli |
| Galderma Laboratories, L.P. | $12.73 | 2022 | |
| Covidien LP | $11.03 | 2019 | |
| Biom'Up Sa | $4.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Laws listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.